Article 27 Jan 2025 FDA Issues Draft Guidance Describing When A Confirmatory Trial Of A Drug Seeking Accelerated Approval Is "Underway" United States Healthcare
Article 16 Jan 2025 FDA Finalizes Guidance On Communication Of Scientific Information On Unapproved Uses And Releases Updated First Amendment Analysis United States Healthcare
Article 02 Jan 2025 Anything Worth Doing Is Worth Doing Right: FDA Issues Draft Guidance On Requirements And Processes For Accelerated Approval United States Healthcare
Article 02 Aug 2024 Non-Binding Guidance: How Drug And Device Companies Can Tackle Internet Misinformation (Podcast) United States Healthcare
Article 11 Mar 2024 Non-Binding Guidance: Preview Of The Second Annual Ropes & Gray Rare Disease Forum (Podcast) United States Healthcare
Article 30 Jan 2024 U.S. Life Sciences Regulatory And Compliance Outlook 2024 (Part II): Product Development And Pricing (Podcast) United States Healthcare
Article 02 Jan 2024 First Circuit Affirms Convictions Of Former Acclarent Executives Related To Off-Label Promotion Of Medical Device United States Healthcare
Article 21 Nov 2023 Non-Binding Guidance: FDA's Draft Guidance On Communication Of Scientific Information On Unapproved Uses Of Medical Products (Podcast) United States Healthcare
Article 30 Oct 2023 Try, Try Again: FDA Issues Draft Guidance On Communication Of Scientific Information On Unapproved Uses Of Medical Products United States Healthcare
Article 07 Mar 2021 Podcast: Non-Binding Guidance: FDA Regulatory Developments In AI And Machine Learning United States Healthcare
Article 02 Oct 2020 Podcast: COVID-19: Non-binding Guidance: Real-World Evidence In Drug Development And The Impact Of The Pandemic United States Coronavirus
Article 10 Mar 2020 Podcast: Non-Binding Guidance: FDA Regulatory And Patent Implications Of The Transition Provision Of The Biologics Price Competition And Innovation Act United States IP
Article 13 Jan 2020 Podcast: Non-Binding Guidance: SEC Disclosure Issues For Life Sciences Companies United States Commercial
Article 10 Oct 2019 Life Sciences Quarterly (Q3 2019): SEC Enforcement And Class Actions Regarding FDA Communications (Video) United States Commercial
Article 23 Sep 2019 Podcast: Non-binding Guidance: Breakthrough Devices Program United States Healthcare
Article 10 Sep 2019 Podcast: Non-binding Guidance: Expedited Review Programs For Drugs And Biologics United States Healthcare
Article 15 Aug 2019 Non-Binding Guidance: Real-World Evidence In Drug Development And FDA Submissions United States Healthcare
Article 08 May 2019 Podcast: Non-binding Guidance: Former FDA Commissioner Scott Gottlieb's Unfinished Business United States Healthcare